Precision Biosciences (DTIL) Accounts Payables (2018 - 2026)
Precision Biosciences (DTIL) reported Accounts Payables of $944000.0 for Q1 2026, up 2.16% year-over-year from $924000.0 in Q1 2025, and up 218.92% quarter-over-quarter from $296000.0 in Q4 2025.
Precision Biosciences (DTIL) Accounts Payables (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Accounts Payables data on file, last reported at $944000.0 in Q1 2026.
- Accounts Payables for Q1 2026 came in at $944000.0, up 2.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $944000.0 (up 2.16% YoY), and the FY2025 annual result was $296000.0, down 77.44% from the prior year.
- Accounts Payables grew to $944000.0 in Q1 2026 per DTIL's latest filing, from $296000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $3.0 million in Q4 2023 and troughed at $296000.0 in Q4 2025.
- A 5-year average of $1.0 million and a median of $944000.0 in 2026 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables soared 354.52% in 2023, then plunged 77.44% in 2025.
- A 5-year view of Accounts Payables shows it stood at $653000.0 in 2022, then jumped by 354.52% to $3.0 million in 2023, then plunged by 55.8% to $1.3 million in 2024, then sank by 77.44% to $296000.0 in 2025, then surged by 218.92% to $944000.0 in 2026.
- Business Quant data shows DTIL's Accounts Payables at $944000.0 in Q1 2026, $296000.0 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 944,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,000.00 |
| Dec 31, 2025 | 296,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 924,000.00 |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 958,000.00 |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Sep 30, 2023 | 531,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 701,000.00 |
| Dec 31, 2022 | 653,000.00 |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 797,000.00 |
| Mar 31, 2022 | 699,000.00 |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 486,000.00 |
| Jun 30, 2021 | 478,000.00 |